Request Demo
Last update 23 Jan 2025
Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.
Private Company|
2017|
Shanghai Shi, China
Last update 23 Jan 2025
Overview
Tags
Neoplasms
Urogenital Diseases
Respiratory Diseases
Chemical drugs
Small molecule drug
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
CTR20230615
一项评价口服HTMC0435片在晚期胆道癌患者中的有效性和安全性的II期临床试验
[Translation] A Phase II Clinical Trial to Evaluate the Efficacy and Safety of Oral HTMC0435 Tablets in Patients with Advanced Biliary Tract Cancer
CTR20230616
一项评价口服HTMC0435片在晚期胰腺癌患者中的有效性和安全性的II期临床试验
[Translation] A Phase II Clinical Trial to Evaluate the Efficacy and Safety of Oral HTMC0435 Tablets in Patients with Advanced Pancreatic Cancer
CTR20233204
一项评价口服HTMC0435片联合替莫唑胺在晚期实体瘤患者中的有效性和安全性的II期临床试验
[Translation] A phase II clinical trial evaluating the efficacy and safety of oral HTMC0435 tablets combined with temozolomide in patients with advanced solid tumors
100 Clinical Results associated with Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.
Login to view more data
Login to view more data
100 Deals associated with Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.
Login to view more data
100 Translational Medicine associated with Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 30 Apr 2025
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
IND Application
3
1
IND Approval
Phase 1 Clinical
3
1
Phase 2 Clinical
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free